These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21976273)

  • 1. New insights into the molecular mechanism of multiple synostoses syndrome (SYNS): mutation within the GDF5 knuckle epitope causes noggin-resistance.
    Schwaerzer GK; Hiepen C; Schrewe H; Nickel J; Ploeger F; Sebald W; Mueller T; Knaus P
    J Bone Miner Res; 2012 Feb; 27(2):429-42. PubMed ID: 21976273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative mutation screening of the NOG, BMPR1B, GDF5, and FGF9 genes indicates further genetic heterogeneity of the facioaudiosymphalangism syndrome.
    van den Ende JJ; Borra V; Van Hul W
    Clin Dysmorphol; 2013 Jan; 22(1):1-6. PubMed ID: 22968293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved bone defect healing by a superagonistic GDF5 variant derived from a patient with multiple synostoses syndrome.
    Degenkolbe E; Schwarz C; Ott CE; König J; Schmidt-Bleek K; Ellinghaus A; Schmidt T; Lienau J; Plöger F; Mundlos S; Duda GN; Willie BM; Seemann P
    Bone; 2015 Apr; 73():111-9. PubMed ID: 25543012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L51P - A BMP2 variant with osteoinductive activity via inhibition of Noggin.
    Albers CE; Hofstetter W; Sebald HJ; Sebald W; Siebenrock KA; Klenke FM
    Bone; 2012 Sep; 51(3):401-6. PubMed ID: 22750402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN.
    Seemann P; Brehm A; König J; Reissner C; Stricker S; Kuss P; Haupt J; Renninger S; Nickel J; Sebald W; Groppe JC; Plöger F; Pohl J; Schmidt-von Kegler M; Walther M; Gassner I; Rusu C; Janecke AR; Dathe K; Mundlos S
    PLoS Genet; 2009 Nov; 5(11):e1000747. PubMed ID: 19956691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trps1 plays a pivotal role downstream of Gdf5 signaling in promoting chondrogenesis and apoptosis of ATDC5 cells.
    Itoh S; Kanno S; Gai Z; Suemoto H; Kawakatsu M; Tanishima H; Morimoto Y; Nishioka K; Hatamura I; Yoshida M; Muragaki Y
    Genes Cells; 2008 Apr; 13(4):355-63. PubMed ID: 18363966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A GDF5 point mutation strikes twice--causing BDA1 and SYNS2.
    Degenkolbe E; König J; Zimmer J; Walther M; Reißner C; Nickel J; Plöger F; Raspopovic J; Sharpe J; Dathe K; Hecht JT; Mundlos S; Doelken SC; Seemann P
    PLoS Genet; 2013; 9(10):e1003846. PubMed ID: 24098149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
    de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
    J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GDF5 is a second locus for multiple-synostosis syndrome.
    Dawson K; Seeman P; Sebald E; King L; Edwards M; Williams J; Mundlos S; Krakow D
    Am J Hum Genet; 2006 Apr; 78(4):708-12. PubMed ID: 16532400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A point mutation in Fgf9 impedes joint interzone formation leading to multiple synostoses syndrome.
    Tang L; Wu X; Zhang H; Lu S; Wu M; Shen C; Chen X; Wang Y; Wang W; Shen Y; Gu M; Ding X; Jin X; Fei J; Wang Z
    Hum Mol Genet; 2017 Apr; 26(7):1280-1293. PubMed ID: 28169396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening and selection of drug-like compounds to block noggin interaction with bone morphogenetic proteins.
    Ahmed S; Metpally RP; Sangadala S; Reddy BV
    J Mol Graph Model; 2010 Apr; 28(7):670-82. PubMed ID: 20137990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2.
    Seemann P; Schwappacher R; Kjaer KW; Krakow D; Lehmann K; Dawson K; Stricker S; Pohl J; Plöger F; Staub E; Nickel J; Sebald W; Knaus P; Mundlos S
    J Clin Invest; 2005 Sep; 115(9):2373-81. PubMed ID: 16127465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct functions of BMP4 and GDF5 in the regulation of chondrogenesis.
    Hatakeyama Y; Tuan RS; Shum L
    J Cell Biochem; 2004 Apr; 91(6):1204-17. PubMed ID: 15048875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of two novel missense mutations in the GDF5 proregion that reduce protein activity and are associated with brachydactyly type C.
    Stange K; Thieme T; Hertel K; Kuhfahl S; Janecke AR; Piza-Katzer H; Penttinen M; Hietala M; Dathe K; Mundlos S; Schwarz E; Seemann P
    J Mol Biol; 2014 Sep; 426(19):3221-3231. PubMed ID: 25092592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
    Kuo PL; Hsu YL; Chang CH; Chang JK
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein signals are required for cartilage formation and differently regulate joint development during skeletogenesis.
    Tsumaki N; Nakase T; Miyaji T; Kakiuchi M; Kimura T; Ochi T; Yoshikawa H
    J Bone Miner Res; 2002 May; 17(5):898-906. PubMed ID: 12009021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
    Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C
    J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter.
    Pan Q; Yu Y; Chen Q; Li C; Wu H; Wan Y; Ma J; Sun F
    J Cell Physiol; 2008 Oct; 217(1):228-41. PubMed ID: 18506848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.